SavedAdd your journal

Journals / Üroonkoloji Bülteni / 2020 / Cilt: 19 - Sayı: 3

Risk of Neoplastic Squall Downstream Cytokine Storm of COVID-19 in Male Patients

Levent TÜRKERİ
Ercüment OVALI
Pages
98–99
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

TÜRKERİ, L., OVALI, E. (2020). Risk of Neoplastic Squall Downstream Cytokine Storm of COVID-19 in Male Patients. Üroonkoloji Bülteni, Cilt: 19 - Sayı: 3, 98–99. https://ajindex.com/articles/334320

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-1034.
  2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
  3. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020;181:271-280.
  4. Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention? Cancer Discov 2020;10:779-782.
  5. Chen YW, Lee MS, Lucht A, et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996.
  6. Mani RS, Amin MA, Li X, et al. Inflammation-ınduced oxidative stress mediates gene fusion formation in prostate cancer. Cell Rep 2016;17:2620-2631.
  7. Gurel B, Lucia MS, Thompson IM Jr, et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2014;23:847-856.
  8. Stikbakke E, Richardsen E, Knutsen T, et al. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study. Int J Cancer 2020;147:84-92.
  9. Wang S, Zhou X, Zhang T, Wang Z. The need for urogenital tract monitoring in COVID-19. Nat Rev Urol 2020;17:314-315.
  10. Sfanos KS, Isaacs WB, De Marzo AM. Infections and inflammation in prostate cancer. Am J Clin Exp Urol 2013;1:3-11.